Skip to main content
. 2021 Feb 8;14(2):e238037. doi: 10.1136/bcr-2020-238037

Figure 4.

Figure 4

CT scan of the head before nivolumab (A) and after seven cycles of nivolumab (B). A 6 mm lesion in the posterior midline of the scalp (arrowed) has completely resolved within this period.